A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri**Supported in part by a grant from TAP Pharmaceuticals, North Chicago, Illinois, and by grant 7-MO1-RR02635-01 from the General Clinical Research Center, Brigham and Women’s Hospital, Boston, Massachusetts.
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Reproductive Medicine
Reference18 articles.
1. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin releasing-hormone agonist;Friedman;Fertil Steril,1987
2. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase;Healy;J Clin Endocrinol Metab,1986
3. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri;Coddington;Fertil Steril,1986
4. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue;Filicori;Am J Obstet Gynecol,1983
5. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study;Maheux;Am J Obstet Gynecol,1985
Cited by 147 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Reoperation rates for recurrence of fibroids after abdominal myomectomy in women with large uterus;PLOS ONE;2021-12-09
2. Uterine Leiomyoma or Sarcoma?;Handbook of Research on Oncological and Endoscopical Dilemmas in Modern Gynecological Clinical Practice;2021
3. Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review;Journal of Clinical Medicine;2020-12-05
4. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy);Cochrane Database of Systematic Reviews;2020-11-23
5. Pelvic Pain;Essentials of Physical Medicine and Rehabilitation;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3